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background:  Some patients develop left atrial thrombi (LAT) despite administration of anticoagulants. Non-vitamin K antagonist oral 
anticoagulants (NOAC) have been reported to be useful for prevention of stroke in patients with non-valvular atrial fibrillation (NVAF). We 
aimed to clarify the characteristics of LAT and/or spontaneous echocardiography contrast (SEC) in patients taking NOAC with NVAF.
Methods:  We studied 159 consecutive patients (103 men, age 67 ± 10 years, mean CHADS2 score: 1.4 ± 1.2, CHA2DS2-VASc score: 
2.9 ± 1.6) who underwent transesophageal echocardiography (TEE) prior to cardioversion or catheter ablation for AF between 2012 and 
2014. We retrospectively assessed the clinical and echocardiographic variables prior to performing TEE. All patients were given NOAC 
(dabigatran: 76 patients, rivaroxaban: 66 patients, apixaban 17 patients) for at least 4 weeks prior to the procedure.
results:  LAT were detected in 6/159 patients (5.7%) and SEC was confirmed in 24/159 patients (15.1%) using TEE. Patients with LAT 
and/or SEC (26/159, 16.4%) showed a high prevalence of structural heart disease (P=0.0038), larger left atrial volume index (LAVI, 
p<0.0001), elevated BNP (P=0.0006), higher E wave (P=0.0297), increased E/e` (P=0.0003) and reduced Left ventricular ejection fraction 
(LVEF, P=0.0002). On multivariate analysis, larger LAVI (P=0.0014, OR 1.860 for each 10 ml/m2 increase in LAVI, 95%CI 1.024-1.104) and 
lower EF (P=0.0089, OR 0.060 for each 10 % decrease in LVEF, 95%CI 0.914-0.987) were independently associated with LAT/SEC.
Conclusion:  Lower LVEF and larger LAVI could be useful for predicting LAT/SEC in patients with NVAF during NOAC administration. For 
patients with low LVEF or large LAVI warfarin administration might be preferable to NOAC.
